“Is it healthy?” That is the first question every parent asks. In the past, amniocentesis was the gold standard—but risky. Today, a blood sample from the mother is enough to peer deep into the unborn child’s genes. The NIPT (Non-Invasive Prenatal Test) is here. But what exactly does it tell us?
How does NIPT work? (The Technology)
It sounds like magic: take blood from the mother and find the baby’s DNA in it. How is that possible?
Fragments of DNA (cell-free DNA) are constantly floating in our blood. When a woman is pregnant, a portion of this DNA (approx. 4-10%) does not come from her, but from the placenta (the baby).
The computer now simply counts millions of DNA snippets.
- Suppose Chromosome 21 normally accounts for 1.3% of all snippets.
- If the child has Trisomy 21 (Down syndrome), there are suddenly 1.35% snippets of Chromosome 21.
- This tiny difference is measurable. Without a needle in the belly. Without a risk of miscarriage.
What can the test do?
In Germany, the focus is on the three most common chromosomal disorders (trisomies):
- Trisomy 21 (Down syndrome): Viable, often with intellectual disabilities and heart defects. (Detection rate >99%)
- Trisomy 18 (Edwards syndrome): Severe malformations, low life expectancy.
- Trisomy 13 (Patau syndrome): Also very severe.
Additionally, the following can be determined (on request and at one’s own expense):
- The sex of the child (only allowed from the 14th week).
- Sex chromosome abnormalities (e.g., Turner syndrome X0).
- Certain microdeletions (very tiny missing pieces, e.g., DiGeorge syndrome). However, the test is often less accurate here.
When does insurance pay?
Since 2022, NIPT has been a covered benefit in Germany (e.g., PraenaTest, Harmony Test). But not for every pregnant woman just as a “screening.” It is paid for if other examinations (e.g., ultrasound) indicate a risk or if the pregnant woman is so anxious that she is under severe psychological strain. The decision is made by the gynecologist together with the patient.
The Limits of the Test
An NIPT is not a diagnostic test, but a screening test. This means:
Test Failures (No-Call): Sometimes the test yields no result. Usually, this is because there is too little fetal DNA in the blood (“low fetal fraction”). Causes can include a high maternal weight or blood thinners (heparin).
The Ethical Debate
Technically, the test is a blessing. Ethically, it is explosive. Critics warn of a “selection society.” If Down syndrome can be detected so easily and without risk—will children with Down syndrome eventually “disappear”? Do parents put themselves under pressure to have a “perfect” child?
You must answer this question for yourselves as parents. The most important question before the test is not “Is my child healthy?”, but: “What would I do if the result is ‘not healthy’?” If the diagnosis would have no consequence for you, you might not need the test at all.
After Birth: Newborn Screening
Genetics does not end with birth. In Germany, blood is taken from every baby in the first days of life (heel prick). This is one of the most successful prevention programs in the world.
It tests for approx. 15-20 congenital metabolic diseases (e.g., Phenylketonuria – PKU). Children with PKU cannot break down protein. If they drink normal milk, their brain is destroyed. But if parents know from Day 1, the child receives a special diet and develops completely normally, goes to university, and lives a healthy life. Here, a simple test decides between “severely disabled” or “healthy.” It is the perfect example of ethically clean, helpful genetics.
Mosaics: When the Placenta Lies
Why is the NIPT sometimes false positive? One reason is “mosaics.” It can happen that only the cells of the placenta have a trisomy, while the baby itself is perfectly healthy (confined placental mosaicism). Since the NIPT only measures placental DNA in the mother’s blood, it triggers an alarm. The child is reported as “sick,” although they are “healthy.” This is exactly why a pregnancy must never be terminated based solely on an NIPT. Only amniocentesis directly examines the child’s cells.
The Rhesus Factor: Saving a Shot?
In addition to chromosomal disorders, the NIPT can do something else great: determine the baby’s Rhesus factor (Rhesus-NIPT).
The Problem: If the mother is Rhesus-negative (rh-) and the baby is Rhesus-positive (rh+), the mother’s body can produce antibodies against the baby’s blood. This is dangerous for subsequent pregnancies. To prevent this, all rh- mothers prophylactically receive a Rhesus shot (a blood product).
The Solution: Often, the baby is also rh- (like the mother). Then the shot is unnecessary. The NIPT can look for the RHD gene in the baby via the mother’s blood. If it doesn’t find it, the baby is rhesus-negative. The mother does not need a shot. This saves resources and unnecessary medication.
Screening vs. Diagnostics: An Important Difference
Many parents confuse probabilities with certainty.
| Method | What it is | Risk | Conclusion |
|---|---|---|---|
| NIPT (Blood Test) | Screening | 0% | “Risk is increased” (Suspicion) |
| Amniocentesis (Puncture) | Diagnostics | 0.5% miscarriage | “Child HAS trisomy” (Proof) |
Frequently Asked Questions
- What is an NIPT?
- NIPT stands for ‘Non-Invasive Prenatal Test.’ It examines the mother’s blood, which contains floating DNA fragments from the child. This allows chromosomal disorders (like Trisomy 21) to be detected without an amniocentesis.
- Is an NIPT dangerous for the baby?
- No, not at all. Only blood is taken from the mother (like a normal blood test). There is no risk of miscarriage, unlike invasive methods.
- When can the test be done?
- Most tests are possible starting from the 10th week of pregnancy. The results are usually available within a few days.